EUVIMEDEUVIMED entdecken
Crossref

A novel chiral oxazoline copper( ii )-based complex inhibits ovarian cancer growth in vitro and in vivo by regulating VEGF/VEGFR2 downstream signaling pathways and apoptosis factors

Rong Fan, Jing-Chen Wei, Bing-Bing Xu, Nan Jin, Xiao-Yi Gong, Xiu-Ying Qin

Dalton Transactions · 2023 · 52 (33) · 11427-11440

DOI: 10.1039/d3dt01648j ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dalton Transactions, 2023. Verfasst von Rong Fan und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Guilin Medical University, Guangxi, Guilin, 541004, China. xyqin6688@163.com. Hauptthemen laut MEDLINE: Copper, Ovarian Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An oxazoline-coordinated copper complex regulates the VEGF/VEGFR2 signaling pathway and apoptosis-related factors to resist ovarian cancer in vivo and in vitro .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CopperOvarian NeoplasmsAnimalsFemaleHumansMiceApoptosisCell MovementCell ProliferationHuman Umbilical Vein Endothelial CellsMice, NudeProto-Oncogene Proteins c-aktSignal TransductionVascular Endothelial Growth Factor A

Substanzen

CopperProto-Oncogene Proteins c-aktVascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • College of Pharmacy, Guilin Medical University, Guangxi, Guilin, 541004, China. xyqin6688@163.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Fan, R., Wei, J. C., Xu, B. B., Jin, N., Gong, X. Y., & Qin, X. Y. (2023). A novel chiral oxazoline copper( ii )-based complex inhibits ovarian cancer growth in vitro and in vivo by regulating VEGF/VEGFR2 downstream signaling pathways and apoptosis factors. Dalton Transactions, 52(33), 11427-11440. https://doi.org/10.1039/d3dt01648j

Vancouver

Fan R, Wei JC, Xu BB, Jin N, Gong XY, Qin XY. A novel chiral oxazoline copper( ii )-based complex inhibits ovarian cancer growth in vitro and in vivo by regulating VEGF/VEGFR2 downstream signaling pathways and apoptosis factors. Dalton Transactions. 2023;52(33):11427-11440. doi:10.1039/d3dt01648j

BibTeX
@article{Fan2023,
  author = {Fan, Rong and Wei, Jing-Chen and Xu, Bing-Bing and Jin, Nan and Gong, Xiao-Yi and Qin, Xiu-Ying},
  title = {A novel chiral oxazoline copper( ii )-based complex inhibits ovarian cancer growth in vitro and in vivo by regulating VEGF/VEGFR2 downstream signaling pathways and apoptosis factors},
  journal = {Dalton Transactions},
  year = {2023},
  volume = {52},
  number = {33},
  pages = {11427--11440},
  doi = {10.1039/d3dt01648j}
}
Kostenlos starten →